Last updated: 2026-09-09 11:04:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Niagen Bioscience, Inc. (NAGE) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $3.11, with a market capitalization of $250.83M and a P/E ratio of 15.34. Over the past 52 weeks, its price has ranged from $2.87 to $10.52. This page covers its latest market performance, valuation, price trends and company information.
$250.83M | |
$3.11 | |
$14.69 | |
$2.87 | |
$3.10 | |
270.00 | |
649.51K | |
15.34 | |
$10.52 | |
$2.87 | |
-- | |
-- |
Niagen Bioscience, Inc. (NAGE) is trading at $3.11 in pre-market trading as of 2026-09-09 11:01:00, up 0.32% ($0.01) from the previous close of $3.10
Pre-market trading shows how investors are pricing NAGE before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Niagen Bioscience, Inc. (NAGE) moved from $3.29 to $3.11, representing a decline of 5.47% ($0.18).
The stock traded between $3.07 and $3.30 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 371.20 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 3.1%
NAGE is currently trading at $3.11, placing it 3.1% of the way from its 52-week low of $2.87 to its 52-week high of $10.52. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 117 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Niagen Bioscience, Inc. (NAGE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.